BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 30755202)

  • 1. sRAGE and early signs of cardiac target organ damage in mild hypertensives.
    Maresca AM; Guasti L; Bozzini S; Mongiardi C; Tandurella N; Corso R; Zerba FG; Squizzato A; Campiotti L; Dentali F; Klersy C; Grandi AM; Falcone C
    Cardiovasc Diabetol; 2019 Feb; 18(1):17. PubMed ID: 30755202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure levels, left ventricular mass and function are correlated with left atrial volume in mild to moderate hypertensive patients.
    Milan A; Caserta MA; Dematteis A; Naso D; Pertusio A; Magnino C; Puglisi E; Rabbia F; Pandian NG; Mulatero P; Veglio F
    J Hum Hypertens; 2009 Nov; 23(11):743-50. PubMed ID: 19262581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients.
    Cuspidi C; Meani S; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
    J Hum Hypertens; 2005 Jun; 19(6):471-7. PubMed ID: 15744331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced nocturnal fall in blood pressure, assessed by two ambulatory blood pressure monitorings and cardiac alterations in early phases of untreated essential hypertension.
    Cuspidi C; Michev I; Meani S; Severgnini B; Fusi V; Corti C; Salerno M; Valerio C; Magrini F; Zanchetti A
    J Hum Hypertens; 2003 Apr; 17(4):245-51. PubMed ID: 12692569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension.
    Cerasola G; Cottone S; Mulé G; Nardi E; Mangano MT; Andronico G; Contorno A; Li Vecchi M; Galione P; Renda F; Piazza G; Volpe V; Lisi A; Ferrara L; Panepinto N; Riccobene R
    J Hypertens; 1996 Jul; 14(7):915-20. PubMed ID: 8818932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ambulatory systolic blood pressure and obesity are independently associated with left ventricular hypertrophic remodeling in children.
    Jing L; Nevius CD; Friday CM; Suever JD; Pulenthiran A; Mejia-Spiegeler A; Kirchner HL; Cochran WJ; Wehner GJ; Chishti AS; Haggerty CM; Fornwalt BK
    J Cardiovasc Magn Reson; 2017 Nov; 19(1):86. PubMed ID: 29117866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension.
    Belsha CW; Wells TG; McNiece KL; Seib PM; Plummer JK; Berry PL
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):410-7. PubMed ID: 9607378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating miRNA29 family expression levels in patients with essential hypertension as potential markers for left ventricular hypertrophy.
    Huang Y; Tang S; Huang C; Chen J; Li J; Cai A; Feng Y
    Clin Exp Hypertens; 2017; 39(2):119-125. PubMed ID: 28287884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control: data from the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni.
    Mancia G; Carugo S; Grassi G; Lanzarotti A; Schiavina R; Cesana G; Sega R;
    Hypertension; 2002 Mar; 39(3):744-9. PubMed ID: 11897756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardio-Ankle Vascular Index as a Marker of Left Ventricular Hypertrophy in Treated Hypertensives: Findings From the Pamela Study.
    Cuspidi C; Facchetti R; Quarti-Trevano F; Dell'Oro R; Mancia G; Grassi G
    Am J Hypertens; 2024 May; 37(6):399-406. PubMed ID: 38441300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum soluble RAGE level inversely correlates with left ventricular hypertrophy in essential hypertension patients.
    Liu Q; Chen HB; Luo M; Zheng H
    Genet Mol Res; 2016 Jul; 15(2):. PubMed ID: 27421025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of different echocardiographic criteria for detection of left ventricular hypertrophy on cardiovascular risk stratification in recently diagnosed essential hypertensives.
    Cuspidi C; Macca G; Sampieri L; Michev I; Fusi V; Salerno M; Severgnini B; Corti C; Magrini F; Zanchetti A
    J Hum Hypertens; 2001 Sep; 15(9):619-25. PubMed ID: 11550108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating miR155 expression level is positive with blood pressure parameters: Potential markers of target-organ damage.
    Huang Y; Chen J; Zhou Y; Tang S; Li J; Yu X; Mo Y; Wu Y; Zhang Y; Feng Y
    Clin Exp Hypertens; 2016; 38(3):331-6. PubMed ID: 27028953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble receptor for advanced glycation end-product levels are related to albuminuria and arterial stiffness in essential hypertension.
    Dimitriadis K; Tsioufis C; Kasiakogias A; Miliou A; Poulakis M; Kintis K; Bafakis I; Benardis E; Tousoulis D; Stefanadis C
    Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):382-8. PubMed ID: 22212601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The frequency of combined target organ damage and the beneficial effect of ambulatory blood pressure monitoring in never treated mild-to-moderate hypertensive patients.
    Torun D; Sezer S; Arat Z; Pelit A; Yigit F; Ozdemir FN
    Int Heart J; 2005 Nov; 46(6):1073-82. PubMed ID: 16394603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interplay between haemodynamic load, brain natriuretic peptide and left atrial size in the early stages of essential hypertension.
    Tsioufis C; Stougiannos P; Taxiarchou E; Skiadas I; Chatzis D; Thomopoulos C; Lalos S; Stefanadis C; Kallikazaros I
    J Hypertens; 2006 May; 24(5):965-72. PubMed ID: 16612260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of soluble receptor for advanced glycation end products levels with hypertensive albuminuria.
    Zheng H; Yuan L; Xie N; Xu H; Xie X; Luo M
    Curr Vasc Pharmacol; 2015; 13(2):259-64. PubMed ID: 24329736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte calpain activity and left ventricular mass in essential hypertension.
    Stella P; Soldati L; Ciurlino D; Vezzoli G; Cusi D; Bianchi G
    J Hypertens; 1997 Dec; 15(12 Pt 2):1775-8. PubMed ID: 9488238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular changes in isolated office hypertension: a blood pressure-matched comparison with normotension and sustained hypertension.
    Grandi AM; Broggi R; Colombo S; Santillo R; Imperiale D; Bertolini A; Guasti L; Venco A
    Arch Intern Med; 2001 Dec 10-24; 161(22):2677-81. PubMed ID: 11732932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.